Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Michael Dustin, Director of Research at the Kennedy Institute of Rheumatology has been awarded two major grants this week, one from the European Research Council (ERC) and the other from the Human Frontier Science Program.

Professor Dustin's research at the Kennedy focuses on immunological synapse (IS), a term he first coined to describe the embrace between T cells and B cells that is necessary to mount an immune response.

ERC ADVANCED GRANT

Understanding the immunological synapse is important for innovation in healthcare and the €2.2M Advanced Grant from the ERC will allow Professor Dustin's group at the Kennedy Institute to address fundamental gaps in our understanding of this process.

The five-year project due to start this November aims to reveal the composition of particular structures related to immunological synapses, defined as synaptic ectosomes, as well as identify ways to manipulate their formation.

"These structures add a new dimension to studies on the immunological synapse" says Professor Dustin. "We are very excited to have this opportunity to understand this new phenomenon; we hope to harness what we learn to improve vaccines and immunotherapy."

HUMAN FRONTIER SCIENCE PROGRAM

Professor Dustin is part of an international team of experts who will be investigating the formation of antibodies, key agents in the body's response to pathogens.

Coordinated by Prof Michael Meyer-Hermann, a systems biologist of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, the €1.2 million project is funded by the Human Frontier Science Program (HFSP).

Results from the three-year research project will form the foundation for specific interventions into the immune response to infections.

Professor Dustin says: "This is a very exciting opportunity to combine mathematical models and experiments while overcoming barriers to international collaboration."

The research program will focus on the information processing in the germinal centres, highly organized tissues that are generated by infections and vaccines to protect us, but also may produce self-destructive antibodies in autoimmune diseases.

The research team will develop methods to study and manipulate human germinal centres in unprecedented detail using powerful imaging methods. Previous studies have used experiments in mice, as methods to study human germinal centres were not previously available. This approach will overcome limitations of traditional mouse models to study germinal centers, particularly divergence of important regulatory mechanisms between mouse and man.

Professor Meyer-Hermann and Professor Dustin are joined by Dr Gabriel Victora of the Whitehead Institute for Biomedical Sciences, Cambridge, USA, and Prof Carola Vinuesa of the Australian National University in Canberra.

The Human Frontier Science Program only funds teams from different continents and is aimed specifically at establishing international cooperation.

Similar stories

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).